Pulse Biosciences Profit Margin

The latest profit margin for PLSE is -10688.38% as of June 2026. That compares with -8176.44% in the prior-year period — down 30.7% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Pulse Biosciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, PLSE's profit margin moved from -8176.44% to -10688.38% — a 30.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pulse Biosciences's valuation or profitability profile.

Against Healthcare companies, PLSE currently prints -10688.38% for profit margin, while the sector average sits near 21.34%. That is roughly 50197.4% below the sector mean. Large gaps often invite a closer look at Pulse Biosciences's growth, margins, and balance sheet.

Profit Margin shows how effectively Pulse Biosciences converts resources into returns. At -10688.38%, PLSE may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -8176.44% in the prior-year period — down 30.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PLSE's profit margin (-10688.38%), review year-over-year change from -8176.44%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.